Skip to content

Study on corelationship of dopamine receiptor polymorphism and clinical efficacy in patients with bipolar mania

Study on corelationship of dopamine receiptor polymorphism and clinical efficacy in patients with bipolar mania

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054696
Enrollment
Unknown
Registered
2021-12-24
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar disorder

Interventions

Bipolar manic episode group:None
Normal control group:None

Sponsors

Zhejiang Provincial Tongde Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for bipolar manic episodes: meet DSM-5 diagnostic criteria for bipolar manic episodes, Young's Mania Scale (YMRS) >= 20 points, no drug treatment, no depressive episodes, Hamilton depression Scale (HAMD) score <7 points; no anxiety attacks, HAMA <7 points; 2. Inclusion criteria for healthy controls: no organic disease, no history of mental illness; YMRS score <8, HAMD <7, HAMA <7; 3. The research subjects have obtained informed consent, all of them are Han nationality, right-handed.

Exclusion criteria

Exclusion criteria: 1. Severe suicidal tendencies; 2. Women who are breastfeeding, pregnant or may become pregnant during the study; 3. History of severe heart, liver, kidney disease, tumor, blood disease, epilepsy and other nervous system diseases; 4. Schizophrenia, psychoactive substance dependence, mental retardation and other serious mental illness patients; 5. Unipolar depression, generalized anxiety disorder; 6. With mixed features and fast cycle features.

Design outcomes

Primary

MeasureTime frame
Test of dopamine receiptor gene polymorphism;

Countries

China

Contacts

Public ContactSun Fengli

Zhejiang Provincial Tongde Hospital

shuimu1980314@sina.com+86 18458316600

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026